ArticleClinical cancer research : an official journal of the American Association for Cancer Research2009

Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphoma.

Stephen M Ansell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.